Pfizer-BioNTech inoculation may have broader effects on the immune system, helping to reduce inflammation in a way similar to ...

Researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended, primary target. They ...

Strand Therapeutics Inc., the programmable mRNA company developing curative therapies for cancer and beyond, will present preclinical data from its STX-003 program at the 2025 annual meetings of the ...

New findings suggest the vaccine may reduce the production of pro-inflammatory mediators to bacterial, fungal or viral infections by reprogramming innate immune cells to regulate inflammation ...

New findings suggest the vaccine may reduce the production of pro-inflammatory mediators to bacterial, fungal or viral ...

For example, during SARS-CoV-2 infection, both T and B lymphocytes play critical roles in viral clearance and the generation ...

While mRNA vaccines represent a transformative platform for infectious disease control, their efficacy in antigen-presenting cells (APCs) remains vulnerable to endogenous regulatory networks, ...

A scientific revolution is underway as researchers push to bring atomic-level precision, once reserved for small molecule ...

RNA-based technologies are a powerful molecular biology toolbox, empowering scientists to decipher the complexities of living ...

Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might ...

The FDA is considering the approval of the Novavax COVID-19 booster after delays amid controversy over its non-mRNA design.